Team:INSA-Lyon/Sponsors
From 2010.igem.org
Line 10: | Line 10: | ||
</style> | </style> | ||
- | |||
<style type="text/css"> | <style type="text/css"> | ||
Line 19: | Line 18: | ||
} | } | ||
+ | #list_extra{list-style-type:circle; margin: 10px auto auto 100px;} | ||
</style> | </style> | ||
Line 35: | Line 35: | ||
<a href="http://www.biomerieux-usa.com/servlet/srt/bio/usa/home"><img class="logosponso" src="http://www.biomerieux.fr/france/img/logo_home.png" alt="logo Biomérieux" style="margin-left: 30px; width: 130px; height: 135px;"/></a><br/> | <a href="http://www.biomerieux-usa.com/servlet/srt/bio/usa/home"><img class="logosponso" src="http://www.biomerieux.fr/france/img/logo_home.png" alt="logo Biomérieux" style="margin-left: 30px; width: 130px; height: 135px;"/></a><br/> | ||
- | <div style="margin-left: 250px;"><p><strong>bioMérieux’s</strong> mission is to contribute to the improvement of public health worldwide through in vitro diagnostics. Throughout its history, our company has committed to four priorities, which today, represent its strength : < | + | <div style="margin-left: 250px;"><p><strong>bioMérieux’s</strong> mission is to contribute to the improvement of public health worldwide through in vitro diagnostics. Throughout its history, our company has committed to four priorities, which today, represent its strength : |
- | + | <p><ol id="list_extra"> | |
- | <li | + | <li>Our independence and expertise in the field of in vitro diagnostics </li> |
- | <li | + | <li>Our international scope</li> |
- | <li | + | <li>Over 45 years of experience and know-how in the field of infectious diseases </li> |
- | <li | + | <li>Scientific and technological innovation is at the heart of the bioMérieux strategy.</li></p> <br/><br/><br/></p> |
<br/></div> | <br/></div> | ||
Line 60: | Line 60: | ||
<div style="padding-left: 200px;"><p><strong>Altran</strong>, European leader in innovation consulting.<br/> | <div style="padding-left: 200px;"><p><strong>Altran</strong>, European leader in innovation consulting.<br/> | ||
Built on an original model, then decentralised to give free rein to initiative, Altran assists its clients at every stage of the innovation cycle in three business lines : | Built on an original model, then decentralised to give free rein to initiative, Altran assists its clients at every stage of the innovation cycle in three business lines : | ||
- | <li | + | <p><ol id="list_extra"> |
- | <li | + | <li>technology and innovation consulting (accounting for nearly half the turnover),</li> |
- | <li | + | <li>organisation and information systems consulting (a third of the turnover),</li> |
+ | <li>strategy and management consulting.</li></p></p> | ||
<br/></div> | <br/></div> | ||
Revision as of 13:40, 27 October 2010
Big thanks to all our sponsors who help make this event possible !
If you want to be part of this adventure, please contact us via email at igem2010.INSA@gmail.com
The INSA Foundation helps students to build on their projects.
bioMérieux’s mission is to contribute to the improvement of public health worldwide through in vitro diagnostics. Throughout its history, our company has committed to four priorities, which today, represent its strength :
- Our independence and expertise in the field of in vitro diagnostics
- Our international scope
- Over 45 years of experience and know-how in the field of infectious diseases
- Scientific and technological innovation is at the heart of the bioMérieux strategy.
Department of Biosciences
The Embassy of France in the United States of America supports the french teams for their participation in this international competition.
Altran, European leader in innovation consulting.
Built on an original model, then decentralised to give free rein to initiative, Altran assists its clients at every stage of the innovation cycle in three business lines :
- technology and innovation consulting (accounting for nearly half the turnover),
- organisation and information systems consulting (a third of the turnover),
- strategy and management consulting.
Sanofi-aventis is a global healthcare company.
Focused on patients’ needs, sanofi-aventis offers a range of essential healthcare assets, including a broad-based product portfolio and a presence worldwide.
Rexam is a leading global consumer packaging group and a leading global beverage can maker. We serve a number of markets including the beverage, personal care, healthcare and food markets.